Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05BA02	SMOFLIPID	G	Soya oil - 6%, Olive oil - 5%, Fish oil - 3%, Medium chain triglycerides - 6%	20%	Injectable emulsion	1,424,473 L.L
B05XA03	HYPOTONIC SALINE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	163,184 L.L
J01DD08	MAGNACEF 400	G	Cefixime - 400mg	400mg	Capsule	1,307,559 L.L
L04AX03	METOJECT	G	Methotrexate disodium - 25mg/0.5ml	25mg/0.5ml	Injectable solution	2,582,865 L.L
M04AA01	ALLOPURINOL BIOGARAN	G	Allopurinol - 100mg	100mg	Tablet	107,507 L.L
N05AX08	RISPERIDONE BIOGARAN	G	Risperidone - 1mg	1mg	Tablet, coated, scored	643,701 L.L
N06DX01	MEMANTINE BIOGARAN	G	Memantine HCl - 20mg	20mg	Tablet, coated	2,444,450 L.L
S01GA52	TRILLERG	G	Antazoline HCl - 0.5mg, Tetryzoline HCl - 0.4mg		Drops solution	310,428 L.L
A03BB01	SCOPINAL	G	Butylscopolamine bromide - 20mg/ml	20mg/ml	Injectable solution	178,731 L.L
A10BA02	GLUFORIN XR 500	G	Metformin HCl - 500mg	500mg	Tablet, film coated, extended release	349,399 L.L
B05BA02	LIPIDEM	G	Triglycerides, Medium Chain - 100g/500ml, Soya bean oil - 80g/500ml, Omega-3 acid triglicerides - 20g/500ml		Injectable emulsion	2,486,109 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	133,856 L.L
C07AG02	CARVEDILOL ARROW	G	Carvedilol - 25mg	25mg	Tablet, film coated, scored	425,998 L.L
D01AE15	LAMIFEN	G	Terbinafine HCl - 1%	1%	Cream	321,178 L.L
H02AB04	MP 500	G	Methylprednisolone - 500mg	500mg	Injectable powder for solution	5,316,241 L.L
J01DD08	MUREX	G	Cefixime - 400mg	400mg	Capsule	679,984 L.L
J02AC03	VIROZOLE 200	G	Voriconazole - 200mg	200mg	Tablet, film coated	47,909,207 L.L
L01CA02	CELLCRISTIN	G	Vincristine sulfate - 1mg/ml	1mg/ml	Injectable solution	1,166,025 L.L
M04AA01	APO-ALLOPURINOL	G	Allopurinol - 100mg	100mg	Tablet	331,929 L.L
N02CC04	RIZATRIPTAN ARROW	G	Rizatriptan - 10mg	10mg	Tablet	1,182,581 L.L
N06DX01	MEMORA	G	Memantine HCl - 20mg	20mg	Tablet, film coated	1,593,413 L.L
R05	COQUELUSEDAL NOURRISSON	G	Grindelia extract - 10mg, Gelsenium extract - 5mg		Suppository	496,170 L.L
A03BB01	? HYOSCINE BUTYLBROMIDE	G	Hyoscine butylbromide - 20mg/ml	20mg/ml	Injectable solution	70,392 L.L
A10BA02	METFORKEY	G	Metformin HCl - 850mg	850mg	Tablet, extended release	357,462 L.L
B05XA03	SODIUM CHLORIDE	G	Sodium chloride - 0.45%	0.45%	Injectable solution	149,393 L.L
C07BB03	ATONIUM PLUS	G	Chlortalidone - 25mg, Atenolol - 50mg		Tablet	738,473 L.L
D01AE15	LAMINOX	G	Terbinafine HCl - 10mg/g	10mg/g	Cream	453,067 L.L
J01DD08	WINEX	G	Cefixime (trihydrate) - 400mg	400mg	Capsule	1,307,559 L.L
J02AC03	VORICONAZOLE STRAGEN	G	Voriconazole - 200mg	200mg	Tablet, coated	40,202,793 L.L
L01CA04	EBERELBIN	G	Vinorelbine (tartrate) - 50mg/5ml	50mg/5ml	Injectable concentrated solution	6,834,783 L.L